Arrowstreet Capital
ORGO icon

Arrowstreet Capital’s Organogenesis Holdings ORGO Stock Holding History

Arrowstreet Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-162,405
Closed -$702K – 2039
2025
Q1 		$702K Buy
+162,405
New +$656K ﹤0.01% 1561
2024
Q2 		– Sell
-73,650
Closed -$209K – 1708
2024
Q1 		$209K Buy
+73,650
New +$250K ﹤0.01% 1576

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's ORGO Position: Q2 2025 in Review

Arrowstreet Capital sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 162,405 shares — an estimated $702K sold.

Arrowstreet Capital first reported a position in ORGO in Q1 2024 and held it in 2 quarters. The position peaked at $702K in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Arrowstreet Capital reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 162,405 Organogenesis Holdings shares in Q2 2025, an estimated $702K.
  • Arrowstreet Capital first reported a position in Organogenesis Holdings in Q1 2024 and held it in 2 quarters.
  • Arrowstreet Capital's Organogenesis Holdings position peaked at $702K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Arrowstreet Capital's 13F filing for Q2 2025, filed 13 Aug 2025.